Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
Relevance. Among the groups at high risk of developing invasive pneumococcal infections, patients with multiple myeloma (MM) stand out among the highest rates of morbidity and mortality due to the presence of profound immunosuppression. Aims: to outline the current state of the problem of vaccine pr...
Main Author: | I. O. Stoma |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2021-01-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/1123 |
Similar Items
-
PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)
by: S.M. Kharit, et al.
Published: (2011-11-01) -
PROPHYLACTIC EFFICACY OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN CHILDREN WITH CHRONIC ADENOTONSILLAR DISEASES
by: S. N. Beniova, et al.
Published: (2015-08-01) -
Vaccination against pneumococcal infection in patients with chronic kidney disease
by: A. A. Tarasova, et al.
Published: (2020-09-01) -
13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01) -
Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study
by: D. V. Bukhanova, et al.
Published: (2018-12-01)